Digest Network How does it work
Network
/
Society
Im
Not verified

ImmunityBio, Inc.

What we write about

BiotechnologyHealthMedicine - variousOncologyPharmaceuticals

42 Press releases

View all press releases
13/11/2025
Market analysis
Industria
Scienza
HIV, AIDS and autoimmune disorders
Medicine - various
Sanità
Biotechnology
Pharmaceuticals
Health
Oncology
New Survey Reveals Non-Muscle Invasive Bladder Cancer Patients Seek More Care Conversations
Source
ImmunityBio, Inc.
Issuer
Business Wire
1.00
0
05/11/2025
stock market
Oncology
Health
HIV, AIDS and autoimmune disorders
Sanità
Pharmaceuticals
Biotechnology
Driven by Strong Demand, ImmunityBio Reports 467% Year-to-Date Unit Growth and $75 Million in Sales Year-to-Date, Up 434% from Q3 2024
Source
ImmunityBio, Inc.
Issuer
Business Wire
1.00
0
08/09/2025
Pharmaceuticals
Health
Oncology
Medicine - various
WEB AND SOCIAL NETWORK
Eventi
Industria
ImmunityBio’s ANKTIVA® Reverses Lymphopenia and Extends Overall Survival in Patients With Advanced Non-Small Cell Lung Cancer Resistant to Checkpoint Therapy
Source
ImmunityBio, Inc.
Issuer
Business Wire
1.00
0
26/08/2025
Oncology
Health
Medicine - various
Scienza
Pharmaceuticals
Biotechnology
Industria
Initial Data Shows 100% Disease Control in 5 Out of 5 Patients With Recurrent Glioblastoma With Two Patients in Near Complete Response Treated With ImmunityBio’s ANKTIVA®, NK Cell Therapy Plus Optune Gio® Device
Source
ImmunityBio, Inc.
Issuer
Business Wire
1.00
0
19/08/2025
HIV, AIDS and autoimmune disorders
Health
Pharmaceuticals
Medicine - various
Industria
ImmunityBio Announces Phase 2 Study of ANKTIVA® in Patients with Long COVID
Source
ImmunityBio, Inc.
Issuer
Business Wire
1.00
0
13/08/2025
Oncology
Health
Food hygiene
HIV, AIDS and autoimmune disorders
Medicine - various
Pharmaceuticals
Biotechnology
Industria
ImmunityBio Reports Complete Responses in Non-Hodgkin Waldenstrom Lymphoma Patients with Chemotherapy-Free, First-In-Class CD19 CAR-NK Immunotherapy
Source
ImmunityBio, Inc.
Issuer
Business Wire
1.00
0
11/08/2025
Biotechnology
Pharmaceuticals
Medical and health
Oncology
Health
Sanità
Medicine - various
Industria
ImmunityBio Announces Houston’s Michael E. DeBakey VA Medical Center Is Among the First VA Hospitals to Administer ANKTIVA® to Bladder Cancer Patients
Source
ImmunityBio, Inc.
Issuer
Business Wire
1.00
0
05/08/2025
Medical and health
HIV, AIDS and autoimmune disorders
Food hygiene
Medicine - various
Management
Biotechnology
Pharmaceuticals
Health
Oncology
stock market
Market analysis
ImmunityBio Reports Q2 Earnings Release Reflecting 60% Increase in Revenue in Q2 2025, With Year-to-Date Sales of $43 Million and 246% Unit Growth Since J-code
Source
ImmunityBio, Inc.
Issuer
Business Wire
1.00
0
25/07/2025
Biotechnology
HIV, AIDS and autoimmune disorders
Health
Pharmaceuticals
Oncology
Finance
ImmunityBio, Inc. Announces Execution of $80 Million Equity Financing from Multiple Institutional Investors
Source
ImmunityBio, Inc.
Issuer
Business Wire
1.00
0
25/07/2025
Biotechnology
Health
Pharmaceuticals
Medicine - various
Oncology
ImmunityBio Reports 60% Increase in Revenue in Q2 2025, with Year-to-Date Sales of $43 Million and 246% Unit Growth Since J-Code with Regulatory Updates
Source
ImmunityBio, Inc.
Issuer
Business Wire
1.00
0

Contact details

Social Media

Followers
0
Compatibility
0